Acurx Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 05/12/2026 | 54.64 K | $202.72 K | 408.63% | 2.01% |
| 05/15/2026 | 31.10 K | $115.38 K | 100.00% | 1.14% | |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 24.82 K | $92.08 K | 99.88% | 0.91% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 04/30/2026 | 20.00 K | $74.00 K | 100.00% | 0.74% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 16.21 K | $60.12 K | 100.00% | 0.60% |
| PROSPECT FINANCIAL SERVICES LLC | 04/24/2026 | 13.79 K | $51.14 K | -30.49% | 0.51% |
| MORGAN STANLEY | 05/15/2026 | 6.50 K | $24.12 K | 0.00% | 0.24% |
| UBS GROUP AG | 05/05/2026 | 6.31 K | $23.42 K | 3,634.91% | 0.23% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 2.30 K | $8.53 K | 0.00% | 0.08% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 05/04/2026 | 1.65 K | $6.12 K | 100.00% | 0.06% |
| NBC SECURITIES, INC. | 04/14/2026 | 1.50 K | $5.57 K | 0.00% | 0.06% |
| WESTERN WEALTH MANAGEMENT, LLC | 05/19/2026 | 1.33 K | $4.92 K | 100.00% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.03 K | $3.83 K | -64.26% | 0.04% |
| 05/14/2026 | 1.00 K | $3.71 K | 100.00% | 0.04% | |
| BARCLAYS PLC | 05/15/2026 | 380 | $1.41 K | 100.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 245 | $909 | -13.43% | 0.01% |
| CORNERSTONE PLANNING GROUP LLC | 05/06/2026 | 167 | $334 | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 100 | $371 | 0.00% | 0.00% |
| BLACKROCK, INC. | 05/13/2026 | 60 | $223 | 0.00% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 05/15/2026 | 59 | $219 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 6 | $22 | -53.85% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 1 | $4 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Acurx Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 28 institutional investors and hedge funds held shares of Acurx Pharmaceuticals Inc. The most heavily invested institutionals were:
JANE STREET GROUP, LLC: 54,642
GEODE CAPITAL MANAGEMENT, LLC: 24,819
Cambridge Investment Research Advisors, Inc.: 20,000
VANGUARD FIDUCIARY TRUST CO: 16,205
Prospect Financial Services LLC: 13,785
MORGAN STANLEY: 6,500
6.74% of Acurx Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 203.22 K shares in the last 24 months. This purchase volume represents approximately $398.32 K in transactions.